Similar articles

• Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis.

  Basili S, Raparelli V, Vestri A, Di Tanna GL, Violi F. Basili S, et al. Thromb Haemost. 2010 Apr;103(4):766-73. doi: 10.1160/TH09-09-0635. Epub 2010 Feb 19. Thromb Haemost. 2010. PMID: 20174763
• Intermittent claudication: a plea for guidelines for medical management.

  Powell JT. Powell JT. Eur J Vasc Endovasc Surg. 2007 Apr;33(4):451-2. doi: 10.1016/j.ejvs.2006.11.014. Epub 2006 Dec 29. Eur J Vasc Endovasc Surg. 2007. PMID: 17196850 No abstract available.
• Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).

  Shigematsu H, Nishibe T, Obitsu Y, Matsuzaki K, Ishida A, Miyata T, Shindo S, Hida K, Ohta T, Ando M, Kawasaki T, Yasugi T, Matsumoto T. Shigematsu H, et al. Int Angiol. 2010 Apr;29(2 Suppl):2-13. Int Angiol. 2010. PMID: 20357743
• Optimal medical management of peripheral arterial disease.

  Rice TW, Lumsden AB. Rice TW, et al. Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835. Vasc Endovascular Surg. 2006. PMID: 16959725 Review.
• Control of hypertension in patients with peripheral artery disease.

  Clement DL. Clement DL. Blood Press. 2006;15(4):251-2. Blood Press. 2006. PMID: 17078187 Review. No abstract available.